deltatrials
Completed PHASE4 NCT00124969

Influence of Amlodipine on the Mortality of Patients With End-Stage Renal Failure

Influence of Amlodipine on the Mortality of Patients With End-Stage Renal Failure (ADAM [Amlodipine and Dialysis Patients, Action on Mortality])

Sponsor: Charite University, Berlin, Germany

Conditions Kidney Failure, Chronic
Interventions Amlodipine Placebo
Updated 5 times since 2017 Last updated: May 7, 2008 Started: Jan 31, 2002 Completion: Oct 31, 2006

A PHASE4 clinical study on Kidney Failure, Chronic, this trial is completed. The trial is conducted by Charite University, Berlin, Germany and has accumulated 5 data snapshots since 2002. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE4

    First recorded

Jan 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Charite University, Berlin, Germany
Data source: Charite University, Berlin, Germany

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Berlin, Germany